2024 annual financial data
Viridian Therapeutics 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -76,926.82%.
Operating income was -299,035,000 USD and net income was -269,949,000 USD.
Operating cash flow was -232,319,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 302,000 USD
- Operating income
- -299,035,000 USD
- Net income
- -269,949,000 USD
- Operating cash flow
- -232,319,000 USD